Apnimed, Inc. SEC filings APMD
Apnimed, Inc. has 55 filings in SEC EDGAR's recent list, going back to Jul 6, 2018. The latest quarterly report (Form 10-Q) was filed on Sep 8, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 8, 2026 | — |
| 10-Q | Quarterly report | Sep 8, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 3, 2026 | Aug 3, 2026 |
| S-8 | Employee stock plan registration | Jul 31, 2026 | — |
| 424B4 | Prospectus | Jul 31, 2026 | — |
| EFFECT | Filing | Jul 30, 2026 | — |
| S-1MEF | Filing | Jul 30, 2026 | — |
| CERT | Filing | Jul 30, 2026 | — |
| 8-A12B | Filing | Jul 29, 2026 | — |
| S-1/A | Amended registration statement | Jul 27, 2026 | — |
| S-1 | Registration statement | Jul 10, 2026 | — |
| DRS/A | Filing | Jun 1, 2026 | — |
| DRS/A | Filing | Apr 22, 2026 | — |
| D | Filing | Mar 27, 2026 | — |
| DRS/A | Filing | Feb 17, 2026 | — |
| D/A | Filing | Dec 8, 2025 | — |
| D/A | Filing | Oct 1, 2025 | — |
| D | Filing | Sep 24, 2025 | — |
| D | Filing | Apr 24, 2025 | — |
| DRS | Filing | Jul 1, 2024 | — |
| D | Filing | Nov 8, 2023 | — |
| D | Filing | Dec 23, 2022 | — |
| D/A | Filing | Nov 1, 2022 | — |
| D | Filing | May 10, 2022 | — |
| D | Filing | Mar 25, 2021 | — |
| D | Filing | Apr 7, 2020 | — |
| D/A | Filing | Aug 7, 2019 | — |
| D/A | Filing | Jan 10, 2019 | — |
| D/A | Filing | Aug 9, 2018 | — |
| D | Filing | Jul 6, 2018 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1745648
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.